Utilization and clinical outcomes of sacubitril/valsartan in Sudanese heart failure patients: A multicenter cross-sectional study
Sacubitril/valsartan (Sac/Val) is a cornerstone therapy for heart failure with reduced ejection fraction (HFrEF), yet its real-world use remains poorly described in Sudan. This multicenter, cross-sectional study aimed to evaluate Sac/Val utilization patterns and clinical outcomes among 170 Sudanese...
Saved in:
| Main Authors: | Alanood Elnaeem Mohamed, Toga K. Mohamed, Bashir A. Yousef, Yaman Walid Kassab, Kannan O. Ahmed |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2025-06-01
|
| Series: | Pharmacia |
| Online Access: | https://pharmacia.pensoft.net/article/150398/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of sacubitril/valsartan in different forms of heart failure
by: Mohammad Abumayyaleh, et al.
Published: (2025-06-01) -
The Effect of Sacubitril/Valsartan on Supraventricular and Ventricular Arrhythmias in Patients With Heart Failure
by: Alireza Arzhangzadeh, et al.
Published: (2025-05-01) -
Potential of valsartan+sacubitril therapy in hypertensive heart disease
by: A. G. Ovchinnikov, et al.
Published: (2021-08-01) -
Dose-dependent renoprotective effects of sacubitril/valsartan in heart failure: a retrospective study
by: Takahiro Kato, et al.
Published: (2025-12-01) -
Efficacy of sacubitril/valsartan among patients with chronic heart failure with reduced ejection fraction
by: Madiha Butt, et al.
Published: (2024-09-01)